SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015987
Filing Date
2021-11-15
Accepted
2021-11-15 16:19:13
Documents
80
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kala-20210930x10q.htm   iXBRL 10-Q 2363678
2 EX-31.1 kala-20210930xex31d1.htm EX-31.1 15228
3 EX-31.2 kala-20210930xex31d2.htm EX-31.2 15188
4 EX-32.1 kala-20210930xex32d1.htm EX-32.1 6727
5 EX-32.2 kala-20210930xex32d2.htm EX-32.2 6826
6 GRAPHIC kala-20210930x10q009.jpg GRAPHIC 23593
7 GRAPHIC kala-20210930x10q010.jpg GRAPHIC 21256
8 GRAPHIC kala-20210930x10q011.jpg GRAPHIC 12453
9 GRAPHIC kala-20210930x10q012.jpg GRAPHIC 48794
10 GRAPHIC kala-20210930x10q013.jpg GRAPHIC 30520
11 GRAPHIC kala-20210930x10q014.jpg GRAPHIC 56188
  Complete submission text file 0001558370-21-015987.txt   8202770

Data Files

Seq Description Document Type Size
12 EX-101.SCH kala-20210930.xsd EX-101.SCH 53013
13 EX-101.CAL kala-20210930_cal.xml EX-101.CAL 53758
14 EX-101.DEF kala-20210930_def.xml EX-101.DEF 197088
15 EX-101.LAB kala-20210930_lab.xml EX-101.LAB 446537
16 EX-101.PRE kala-20210930_pre.xml EX-101.PRE 315583
17 EXTRACTED XBRL INSTANCE DOCUMENT kala-20210930x10q_htm.xml XML 1210484
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38150 | Film No.: 211410960
SIC: 2834 Pharmaceutical Preparations